Rheumatoid arthritis trials in China

In China 53 Also abroad 351

53 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis
Where
Hangzhou
Age
18 years to 85 years
People
30
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT07491016
No phaseTaking people
A RWS of SC MTX in Chinese RA Patients
Where
Beijing
Age
18 years and over
People
10,000
Run by
Peking University People's Hospital
See details and how to joinNCT07463937
No phaseTaking people
HiSCs in the Treatment of Rheumatoid Arthritis
Where
Shanghai
Age
18 years to 65 years
People
15
Run by
Shanghai Changzheng Hospital
See details and how to joinNCT06947746
Early phase 1Taking people
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Where
Shanghai
Age
18 years to 70 years
People
60
Run by
Changhai Hospital
See details and how to joinNCT07246096
Early phase 1Taking people
Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis
Where
Wuhan
Age
18 years to 70 years
People
12
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07347860
Phase 1Taking people
An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis
Where
Wuhan
Age
18 years to 75 years
People
28
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06946199
Phase 1Taking people
A Phase 1 Study of ADI-001 in Rheumatoid Arthritis
Where
Shanghai
Age
18 years to 80 years
People
25
Run by
Adicet Therapeutics
See details and how to joinNCT07100873
No phaseNot yet taking people in China
Rehabilitation Exercise Intervention for Rheumatoid Arthritis Patients Using Artificial Intelligence-Based Exercise Prescription System
Where
Beijing
Age
18 years and over
People
147
Run by
Peking University Third Hospital
See details and how to joinNCT07246811
Early phase 1Taking people
Safety Study of CC312 in Autoimmune Disease Patients
Where
Tianjin
Age
18 years and over
People
18
Run by
CytoCares Inc
See details and how to joinNCT06888960
No phaseTaking people
Research on the Application of 99mTc-TCR-FAPI SPECT Imaging in Rheumatoid Arthritis
Where
Beijing
Age
18 years to 75 years
People
20
Run by
Luo Yaping
See details and how to joinNCT07138729
No phaseTaking people
Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases
Where
Hefei
Age
18 years and over
People
18
Run by
Anhui Provincial Hospital
See details and how to joinNCT07121777
Phase 3Enrolling by invitation
Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis
Where
Beijing
Age
18 years to 75 years
People
615
Run by
Beijing VDJBio Co., LTD.
See details and how to joinNCT06726096
Phase 1Taking people
A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
Where
Beijing
Age
18 years to 75 years
People
102
Run by
Shanghai Qilu Pharmaceutical Research and Development Center LTD
See details and how to joinNCT06946641
Early phase 1Taking people
The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
Where
Wuhan
Age
18 years and over
People
24
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07001956
No phaseTaking people
CAR-T Cells Therapy for Patients With Autoimmune Diseases
Where
Hefei
Age
18 years and over
People
18
Run by
Anhui Provincial Hospital
See details and how to joinNCT07052565
Phase 4Not yet taking people in China
Telitacicept for the Treatment of Refractory RA
Where
Beijing
Age
18 years to 70 years
People
30
Run by
Chinese SLE Treatment And Research Group
See details and how to joinNCT07008196
Early phase 1Not yet taking people in China
Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection
Where
Wuhan
Age
18 years and over
People
24
Run by
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT06982547
No phaseTaking people
Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis
Where
Hangzhou
Age
18 years to 85 years
People
20
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT06979271
Early phase 1Not yet taking people in China
Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Where
Suzhou
Age
18 years and over
People
15
Run by
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT06970951
Early phase 1Taking people
An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis
Where
Nanjing
Age
18 years to 70 years
People
24
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06613490
Phase 4Not yet taking people in China
A Study of Iguratimod in Combination With Tofacitinib in RA Patients
Where
Yiwu
Age
18 years to 80 years
People
200
Run by
Jie Chang
See details and how to joinNCT06945666
No phaseTaking people
An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
Where
Changsha
Age
18 years and over
People
18
Run by
The First Affiliated Hospital of University of Science and Technology of China
See details and how to joinNCT06503224
Phase 1Taking people
A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis
Where
Shanghai
Age
18 years to 75 years
People
54
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06857227
No phaseTaking people
Safety and Efficacy of SWK002 in Patients With D2T-Rheumatoid Arthritis
Where
Changsha
Age
18 years and over
People
18
Run by
The First Affiliated Hospital of University of Science and Technology of China
See details and how to joinNCT06503237
Phase 4Taking people
Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis
Where
Beijing
Age
18 years to 75 years
People
340
Run by
China-Japan Friendship Hospital
See details and how to joinNCT05540938